Response of cardiac mast cells to atrial natriuretic peptide

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 293, Issue 2, 2007, Pages

  Murray, David B ^a   Gardner, Jason D ^a   Levick, Scott P ^a   Brower, Gregory L ^a   Morgan, Loren G ^a   Janicki, Joseph S ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Atrial natriuretic factor; Extracellular matrix; Fistula; Isolated heart; Ventricular remodeling

Indexed keywords

ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR ANTAGONIST; COLLAGEN; GELATINASE A; HISTAMINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTOCAVAL FISTULA; ARTICLE; CARDIOVASCULAR PARAMETERS; CELL ISOLATION; CONTROL GROUP; CONTROLLED STUDY; DEGRANULATION; DIASTOLE; ENZYME ACTIVITY; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; HEART WORK; HISTAMINE RELEASE; ISOLATED HEART; MALE; MAST CELL; NONHUMAN; PERFUSION; PERITONEUM MAST CELL; PRIORITY JOURNAL; RAT; SYSTOLE;

ANIMALS; AORTA, ABDOMINAL; ARTERIOVENOUS FISTULA; ASCITIC FLUID; ATRIAL NATRIURETIC FACTOR; CELL DEGRANULATION; COLLAGEN; DISEASE MODELS, ANIMAL; HISTAMINE RELEASE; HYPERTROPHY, LEFT VENTRICULAR; MALE; MAST CELLS; MATRIX METALLOPROTEINASE 2; MYOCARDIUM; PEPTIDES, CYCLIC; RATS; RATS, SPRAGUE-DAWLEY; VENA CAVA, INFERIOR; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 34547920719     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01388.2006     Document Type: Article

References (32)

1. Abassi Z, Karram T, Ellaham S, Winaver J, Hoffman A. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance. Pharmacol Ther 102: 223-241, 2004.
2. Abassi ZA, Brodsky S, Karram T, Dobkin I, Winaver J, Hoffman A. Temporal changes in natriuretic and antinatriuretic systems after closure of a large arteriovenous fistula. Cardiovasc Res 51: 567-576, 2001.
3. Abassi ZA, Winaver J, Hoffman A. Large A-V fistula: pathophysiological consequences and therapeutic perspectives. Curr Vasc Pharmacol 1: 347-354, 2003.
4. Brower GL, Chancey AL, Thanigaraj S, Matsubara BB, Janicki JS. Cause-and-effect relationship between myocardial mast cell number and matrix metalloproteinase activity. Am J Physiol Heart Circ Physiol 283: H518-H525, 2002.
5. Brower GL, Henegar JR, Janicki JS. Temporal evaluation of left ventricular remodeling and function in rats with chronic volume overload. Am J Physiol Heart Circ Physiol 271: H2071-H2078, 1996.
6. Brower GL, Janicki JS. Contribution of ventricular remodeling to pathogenesis of heart failure in rats. Am J Physiol Heart Circ Physiol 280: H674-H683, 2001.
7. Brower GL, Janicki JS. Pharmacologic inhibition of mast cell degranulation prevents left ventricular remodeling induced by chronic volume overload in rats. J Card Fail 11: 548-556, 2005.
8. Chai OH, Lee YH, Han EH, Kim HT, Lee MS, Song CH. Atrial natriuretic peptide induces rat peritoneal mast cell activation by cGMP-independent and calcium uptake-dependent mechanism. Exp Mol Med 32: 179-186, 2000.
9. Chancey AL, Brower GL, Janicki JS. Cardiac mast cell-mediated activation of gelatinase and alteration of ventricular diastolic function. Am J Physiol Heart Circ Physiol 282: H2152-H2158, 2002.
10. El Ayoubi R, Menaouar A, Gutkowska J, Mukaddam-Daher S. Urinary responses to acute moxonidine are inhibited by natriuretic peptide receptor antagonist. Br J Pharmacol 145: 50-56, 2005.
11. Forman MF, Brower GL, Janicki JS. Spontaneous histamine secretion during isolation of rat cardiac mast cells. Inflamm Res 53: 453-457, 2004.
12. Franco V, Chen YF, Oparil S, Feng JA, Wang D, Hage F, Perry G. Atrial natriuretic peptide dose-dependently inhibits pressure overload-induced cardiac remodeling. Hypertension 44: 746-750, 2004.
13. Horio T, Nishikimi T, Yoshihara F, Matsuo H, Takishita S, Kangawa K. Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes. Hypertension 35: 19-24, 2000.
14. Huang M, Hester RL, Guyton AC. Hemodynamic changes in rats after opening an arteriovenous fistula. Am J Physiol Heart Circ Physiol 262: H846-H851, 1992.
15. Kishimoto I, Rossi K, Garbers DL. A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy. Proc Natl Acad Sci USA 98: 2703-2706, 2001.
16. Knowles JW, Esposito G, Mao L, Hagaman JR, Fox JE, Smithies O, Rockman HA, Maeda N. Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice. J Clin Invest 107: 975-984, 2001.
17. Langenickel T, Pagel I, Hohnel K, Dietz R, Willenbrock R. Differential regulation of cardiac ANP and BNP mRNA in different stages of experimental heart failure. Am J Physiol Heart Circ Physiol 278: H1500-H1506, 2000.
18. Mori T, Chen YF, Feng JA, Hayashi T, Oparil S, Perry GJ. Volume overload results in exaggerated cardiac hypertrophy in the atrial natriuretic peptide knockout mouse. Cardiovasc Res 61: 771-779, 2004.
19. Murray DB, Gardner JD, Brower GL, Janicki JS. Endothelin-1 mediates cardiac mast cell degranulation, matrix metalloproteinase activation, and myocardial remodeling in rats. Am J Physiol Heart Circ Physiol 287: H2295-H2299, 2004.
20. Nakanishi M, Saito Y, Kishimoto I, Harada M, Kuwahara K, Takahashi N, Kawakami R, Nakagawa Y, Tanimoto K, Yasuno S, Usami S, Li Y, Adachi Y, Fukamizu A, Garbers DL, Nakao K. Role of natriuretic peptide receptor guanylyl cyclase-A in myocardial infarction evaluated using genetically engineered mice. Hypertension 46: 441-447, 2005.
21. Nishikimi T, Hagaman JR, Takahashi N, Kim HS, Matsuoka H, Smithies O, Maeda N. Increased susceptibility to heart failure in response to volume overload in mice lacking natriuretic peptide receptor-A gene. Cardiovasc Res 66: 94-103, 2005.
22. Nishikimi T, Maeda N, Matsuoka H. The role of natriuretic peptides in cardioprotection. Cardiovasc Res 69: 318-328, 2006.
23. Opgenorth TJ, Budzik GP, Mollison KW, Davidsen SK, Holst MR, Holleman WH. Atrial peptides induce mast cell histamine release. Peptides 11: 1003-1007, 1990.
24. Patel JB, Valencik ML, Pritchett AM, Burnett JC Jr, McDonald JA, Redfield MM. Cardiac-specific attenuation of natriuretic peptide A receptor activity accentuates adverse cardiac remodeling and mortality in response to pressure overload. Am J Physiol Heart Circ Physiol 289: H777-H784, 2005.
25. Poulos JE, Gower WR Jr, Sullebarger JT, Fontanet HL, Vesely DL. Congestive heart failure: increased cardiac and extracardiac atrial natriuretic peptide gene expression. Cardiovasc Res 32: 909-919, 1996.
26. Scheuermann M, Dietz R, Willenbrock R. Acute and chronic neutral endopeptidase inhibition and the natriuretic response to acute volume expansion. Eur J Pharmacol 347: 245-252, 1998.
27. Spinale FG, Coker ML, Thomas CV, Walker JD, Mukherjee R, Hebbar L. Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function. Circ Res 82: 482-495, 1998.
28. Su X, Brower G, Janicki JS, Chen YF, Oparil S, Dell'Italia LJ. Differential expression of natriuretic peptides and their receptors in volume overload cardiac hypertrophy in the rat. J Mol Cell Cardiol 31: 1927-1936, 1999.
29. Suga H, Sagawa K, Shoukas AA. Load independence of the instantaneous pressure-volume ratio of the canine left ventricle and effects of epinephrine and heart rate on the ratio. Circ Res 32: 314-322, 1973.
30. Weber KT, Pick R, Silver MA, Moe GW, Janicki JS, Zucker IH, Armstrong PW. Fibrillar collagen and remodeling of dilated canine left ventricle. Circulation 82: 1387-1401, 1990.
31. Woods RL. Cardioprotective functions of atrial natriuretic peptide and B-type natriuretic peptide: a brief review. Clin Exp Pharmacol Physiol 31: 791-794, 2004.
32. Yoshida H, Inagaki Y, Yamaki K, Beppu Y, Kawashima T, Takagi K. Histamine release induced by human natriuretic peptide from rat peritoneal mast cells. Regul Pept 61: 45-49, 1996.